Correction: Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

In this article (Clin Cancer Res 2014;20:233–45), which was published in the January 1, 2014, issue of Clinical Cancer Research (1), the affiliation for Dr. Jordi Rodon was listed incorrectly. Dr. Rodon's affiliation should read as follows: Vall d'Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain. The publisher regrets this error.